Preclinical Assessment of FHIT Gene Replacement Therapy in Human Leukemia Using a Chimeric Adenovirus, Ad5/F35

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-2581
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Novel Ad5/11 Chimeric Oncolytic Adenovirus for Improved Glioma Therapy

International Journal of Oncology
Cancer ResearchOncology
2012English

Killing Effect of Ad5/F35-Ape1 siRNA Recombinant Adenovirus in Combination With Hematoporphrphyrin Derivative-Mediated Photodynamic Therapy on Human Nonsmall Cell Lung Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

5. Suppression of Protein Phosphatase 2A Activity Enhances Ad5/F35 Adenovirus Transduction Efficiency in Human Normal B Lymphocytes and Cell Lines

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Effective Gene-Viral Therapy of Leukemia by a New Fiber Chimeric Oncolytic Adenovirus Expressing TRAIL: In Vitro and in Vivo Evaluation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Gene Immunotherapy of Chronic Lymphocytic Leukemia: A Phase I Study of Intranodally Injected Adenovirus Expressing a Chimeric CD154 Molecule

Cancer Research
Cancer ResearchOncology
2012English

Do FHIT Gene Alterations Play a Role in Human Solid Tumors?

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Adenovirus-Mediated P53 Gene Therapy Inhibits Human Sarcoma Tumorigenicity

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2000English

Adenovirus Vectors for Gene Therapy

Uirusu. Journal of virology
Medicine
2003English

A Preclinical Approach for Gene Therapy of Β-Thalassemia

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy